Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Current Liabilities ₹62 Cr₹109 Cr₹113 Cr₹78 Cr₹59 Cr

What is the latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹62 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹62 Cr
Mar2024₹109 Cr
Mar2023₹113 Cr
Mar2022₹78 Cr
Mar2017₹59 Cr

How is Total Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹62 Cr
-43.19
Mar2024 ₹109 Cr
-3.89
Mar2023 ₹113 Cr
44.60
Mar2022 ₹78 Cr
33.01
Mar2017 ₹59 Cr -

Compare Total Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,231.4 Cr -3.3% -6.1% -30.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.3%

-6.1%

-30.1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses